| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.23M | — |
| Operating expense | — | — |
| Net income | -18.32M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
| Period | Total return |
|---|---|
| All-time high | $32.23 (Jun 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AKTS would be worth today ›No. Aktis Oncology, Inc. has not paid a dividend in the past 12 months.
Aktis Oncology, Inc. stock trades on NASDAQ under the ticker symbol AKTS.
Aktis Oncology, Inc. is part of the Healthcare sector.
Aktis Oncology, Inc. has a market cap of 1.34B USD, based on the latest quote.
Aktis Oncology, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.